1-2 of 2
Karen E Thudium
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of a Global Registration Trial of the Efficacy and Safety of CTL019 in Pediatric and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

Stephan A. Grupp, MD PhD, Theodore W Laetsch, MD, Jochen Buechner, MD PhD, Henrique Bittencourt, MD PhD, Shannon L Maude, MD PhD, Michael R. Verneris, MD, Gary D Myers, MD, Michael W Boyer, MD, Susana Rives, MD PhD, Barbara De Moerloose, MD, Eneida R. Nemecek, MD, Krysta Schlis, MD, Paul L. Martin, MD PhD, Muna Qayed, MD MSc, Peter Bader, MD, Hidefumi Hiramatsu, MD PhD, Francoise Mechinaud, MDFRACP, Gregory A Yanik, MD, Christina Peters, MD, Andrea Biondi, MD, Andre Baruchel, MD, Nicolas Boissel, MD PhD, Joerg Krueger, MD, Carl H June, MD, Kapildeb Sen, PhD, Yiyun Zhang, PhD, Karen E Thudium, PharmD, MS, Patricia A Wood, MD PhD, Tetiana Taran, MD, Michael A Pulsipher, MD
Journal: Blood
Blood (2016) 128 (22): 221.
https://doi.org/10.1182/blood.V128.22.221.221
Published: 2016
Journal Articles

Apoptotic and Non-Apoptotic Cellular Pathways Executed by Bortezomib (BTZ) in Rituximab-Resistant Lymphomas

Juan Gu, PhD, Francisco J. Hernandez-Ilizaliturri, MD, Cory Mavis, BSc, MSc, Natalie M Czuczman, Karen E Thudium, George Deeb, MD, John Gibbs, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2011) 118 (21): 4967.
https://doi.org/10.1182/blood.V118.21.4967.4967
Published: 2011